# Ovarian Hyperstimulation Syndrome Prevention

> **NCT06739759** · NA · RECRUITING · sponsor: **Aljazeera Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Ovarian Hyper Stimulation Syndrome (OHSS)

## Interventions

- **DRUG:** Antagonist protocol for IVF
- **DRUG:** Modified Agonist protocol for IVF with additive treatments as HCQ

## Key facts

- **NCT ID:** NCT06739759
- **Lead sponsor:** Aljazeera Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-17
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-07-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2024-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06739759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06739759, "Ovarian Hyperstimulation Syndrome Prevention". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06739759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*